• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Atea Pharmaceuticals Inc (NQ: AVIR )

    3.360 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Atea Pharmaceuticals Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug Interaction Profile at Conference on Retroviruses and Opportunistic Infections
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 35 stocks hit new 52-week lows. 
    Via Benzinga
    Atea Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharma's Investigational Dengue Treatment Fast Tracked In US
    Via Benzinga
    Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir
    Via Benzinga
    Recap: Atea Pharmaceuticals Q2 Earnings
      Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Atea Pharmaceuticals Highlights Strategic Priorities for 2023
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharmaceuticals Announces First Patient Dosed in SUNRISE-3 Phase 3 Registrational Trial of Bemnifosbuvir, an Investigational Oral Antiviral for the Treatment of COVID-19
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Short Volatility Alert: Atea Pharmaceuticals
    On Tuesday, shares of Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) experienced volatile short activity. After the activity, the stock price went down -1.73% to $7.38. The... 
    Via Benzinga
    Atea Pharmaceuticals: Q1 Earnings Insights
    Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Atea Pharmaceuticals to Present at the Jefferies London Healthcare Conference
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Atea Pharmaceuticals Earnings Preview
    Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Atea... 
    Via Benzinga
    Atea Pharmaceuticals Presents Favorable AT-752 Phase 1 Data for Treatment of Dengue Fever at American Society of Tropical Medicine & Hygiene 2022 Annual Meeting
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Earnings Scheduled For February 28, 2022
    Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
    Via Benzinga
    Atea Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call on November 7, 2022
    From Atea Pharmaceuticals, Inc.
    Via GlobeNewswire
    Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion?
    Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now? 
    Via Investor's Business Daily
    Stocks Selling For Less Than Cash Per Share
    How do you go about choosing a stock to buy in these volatile times? One strategy is to look for stocks that are not only selling below their book value, but also below their cash per share, especially... 
    Via Talk Markets
    The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Earnings Preview For Atea Pharmaceuticals
    Atea Pharmaceuticals (NASDAQ:AVIR) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Atea... 
    Via Benzinga
    How To Attend Atea Pharmaceuticals Q1 2022 Earnings Conference Call
    Atea Pharmaceuticals (NASDAQ:AVIR) will host a conference call at 10:00 AM ET on May 10, 2022, to discuss Q1 2022 earnings results. 
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
    Via Benzinga
    NASDAQ:AVIR Investor Notice: Investigation over Potential Wrongdoing at Atea Pharmaceuticals, Inc.
    San Diego, CA -- (SBWIRE) -- 04/05/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Atea Pharmaceuticals, Inc. 
    Via SBWire
    30 Stocks Moving in Tuesday's Pre-Market Session
    Gainers Incannex Healthcare Limited (NASDAQ: IXHL) rose 118.2% to $49.97 in pre-market trading after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary... 
    Via Benzinga
    44 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3... 
    Via Benzinga
    27 Stocks Moving in Monday's Pre-Market Session
    Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6... 
    Via Benzinga
    Atea Pharmaceuticals: Q4 Earnings Insights
    Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Monday, February 28, 2022 at 04:01 PM. Here's what investors need to know about the announcement.... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.